Leucovorin: Difference between revisions
(Leucovorin) |
ClaireLewis (talk | contribs) |
||
| (9 intermediate revisions by 6 users not shown) | |||
| Line 6: | Line 6: | ||
==Adult Dosing== | ==Adult Dosing== | ||
*Fluorouracil adjuvant | *Fluorouracil adjuvant treatment, adv. colorectal CA | ||
**high dose: | **high dose: 200mg/m^2 IV QD x5 days | ||
**low dose: | **low dose: 20mg/m^2 IV QD x5 days | ||
*Leucovorin rescue, high-dose methotrexate | *Leucovorin rescue, high-dose [[methotrexate]] | ||
**normal methotrexate elimination: | **normal methotrexate elimination: 15mg PO/IM/IV q6h x10 doses | ||
**delayed late methotrexate elimination: | **delayed late methotrexate elimination: 15mg PO/IM/IV q6h; Max: 25mg/dose PO, May give higher doses IM/IV | ||
*Delayed early methotrexate elimination and/or acute renal injury: | *Delayed early methotrexate elimination and/or acute renal injury: 150mg IV q3h until methotrexate level <1 micromolar, then 15mg IV q3h | ||
*Leucovorin rescue, methotrexate overdose: | *Leucovorin rescue, methotrexate overdose: 10mg/m^2 PO/IM/IV q6h | ||
*Folate antagonist overdose | *Folate antagonist overdose | ||
**pemetrexed: | **pemetrexed: 50mg/m^2 IV q6h x8 days; Start: 100mg/m^2 IV x1 | ||
**pyrimethamine, trimethoprim: 5- | **pyrimethamine, trimethoprim: 5-15mg PO/IM/IV QD until hematopoiesis restored | ||
*Megaloblastic anemia, folate-deficient: < | *Megaloblastic anemia, folate-deficient: <1mg IM/IV QD | ||
**Max: | **Max: 1mg/day | ||
==Pediatric Dosing== | ==Pediatric Dosing== | ||
*Leucovorin rescue, high-dose methotrexate | *Leucovorin rescue, high-dose methotrexate | ||
**normal methotrexate elimination: | **normal methotrexate elimination: 10mg/m^2 PO/IM/IV q6h x10 doses; Start: 24h after methotrexate start; Max: 25mg/dose PO | ||
**delayed late methotrexate elimination: | **delayed late methotrexate elimination: 10mg/m^2 PO/IM/IV q6h; Max: 25mg/dose PO | ||
**delayed early methotrexate elimination and/or acute renal injury: | **delayed early methotrexate elimination and/or acute renal injury: 100mg/m^2 IV q3h until methotrexate level <1 micromolar, then 10mg/m^2 IV q3 | ||
*Leucovorin rescue, methotrexate overdose: | *Leucovorin rescue, methotrexate overdose: 10mg/m^2 PO/IM/IV q6h | ||
*Folate antagonist overdose: 5- | *Folate antagonist overdose: 5-15mg PO/IM/IV QD until hematopoiesis restored | ||
*Megaloblastic anemia, folate-deficient: < | *Megaloblastic anemia, folate-deficient: <1mg IM/IV QD | ||
**Max: | **Max: 1mg/day | ||
==Special Populations== | ==Special Populations== | ||
*Pregnancy Risk Factor: C | *Pregnancy Risk Factor: C | ||
*Breast Feeding: Leucovorin is a form of folic acid and is present in breast milk which may be beneficial to the newborn. | |||
===Renal Dosing=== | ===Renal Dosing=== | ||
| Line 55: | Line 56: | ||
==Adverse Reactions== | ==Adverse Reactions== | ||
===Serious=== | ===Serious=== | ||
*anaphylactoid | *anaphylactoid reaction | ||
*seizures | *seizures | ||
*syncope | *syncope | ||
| Line 75: | Line 76: | ||
==References== | ==References== | ||
<Epocrates, UpToDate> | <Epocrates, UpToDate> | ||
[[Category: | [[Category:Pharmacology]] [[Category:Heme/Onc]] | ||
Latest revision as of 22:52, 22 September 2019
Administration
- Type: Antidote; Chemotherapy Modulating Agent; Rescue Agent (Chemotherapy)
- Dosage Forms: 5,10,15,25
- Routes of Administration: IV, IM
- Common Trade Names: Lederle Leucovorin
Adult Dosing
- Fluorouracil adjuvant treatment, adv. colorectal CA
- high dose: 200mg/m^2 IV QD x5 days
- low dose: 20mg/m^2 IV QD x5 days
- Leucovorin rescue, high-dose methotrexate
- normal methotrexate elimination: 15mg PO/IM/IV q6h x10 doses
- delayed late methotrexate elimination: 15mg PO/IM/IV q6h; Max: 25mg/dose PO, May give higher doses IM/IV
- Delayed early methotrexate elimination and/or acute renal injury: 150mg IV q3h until methotrexate level <1 micromolar, then 15mg IV q3h
- Leucovorin rescue, methotrexate overdose: 10mg/m^2 PO/IM/IV q6h
- Folate antagonist overdose
- pemetrexed: 50mg/m^2 IV q6h x8 days; Start: 100mg/m^2 IV x1
- pyrimethamine, trimethoprim: 5-15mg PO/IM/IV QD until hematopoiesis restored
- Megaloblastic anemia, folate-deficient: <1mg IM/IV QD
- Max: 1mg/day
Pediatric Dosing
- Leucovorin rescue, high-dose methotrexate
- normal methotrexate elimination: 10mg/m^2 PO/IM/IV q6h x10 doses; Start: 24h after methotrexate start; Max: 25mg/dose PO
- delayed late methotrexate elimination: 10mg/m^2 PO/IM/IV q6h; Max: 25mg/dose PO
- delayed early methotrexate elimination and/or acute renal injury: 100mg/m^2 IV q3h until methotrexate level <1 micromolar, then 10mg/m^2 IV q3
- Leucovorin rescue, methotrexate overdose: 10mg/m^2 PO/IM/IV q6h
- Folate antagonist overdose: 5-15mg PO/IM/IV QD until hematopoiesis restored
- Megaloblastic anemia, folate-deficient: <1mg IM/IV QD
- Max: 1mg/day
Special Populations
- Pregnancy Risk Factor: C
- Breast Feeding: Leucovorin is a form of folic acid and is present in breast milk which may be beneficial to the newborn.
Renal Dosing
- Not defined
Hepatic Dosing
- Not defined
Contraindications
- Allergy to class/drug
- intrathecal administration
- caution if pernicious anemia
- caution if megaloblastic anemia, vitamin B12 deficient
- caution if vitamin B-12 deficiency
Adverse Reactions
Serious
- anaphylactoid reaction
- seizures
- syncope
Common
- urticaria
- nausea/vomiting (IV use)
Pharmacology
- Half-life: 6hr
- Metabolism: liver, GI, CYP450
- Excretion: Urine
Mechanism of Action
Comments
See Also
References
<Epocrates, UpToDate>
